These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 5038771)
21. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. Whaley K; Schur PH; Ruddy S J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459 [TBL] [Abstract][Full Text] [Related]
22. Genetic deficiencies of the complement system. Lachmann PJ Boll Ist Sieroter Milan; 1974; 53(1):suppl:195-207. PubMed ID: 4604506 [No Abstract] [Full Text] [Related]
23. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Ross SC; Densen P Medicine (Baltimore); 1984 Sep; 63(5):243-73. PubMed ID: 6433145 [TBL] [Abstract][Full Text] [Related]
24. Decreased synthesis of the third component of complement (C3) in hypocomplementemic systemic lupus erythematosus. Sliwinski AJ; Zvaifler NJ Clin Exp Immunol; 1972 May; 11(1):21-9. PubMed ID: 5038771 [TBL] [Abstract][Full Text] [Related]
25. Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child. Yamazaki-Nakashimada MA; Duran-McKinster C; Ramírez-Vargas N; Hernandez-Bautista V Pediatr Dermatol; 2009; 26(4):445-7. PubMed ID: 19689522 [TBL] [Abstract][Full Text] [Related]
27. Metabolic behavior of C3 in normal, C4-deficient (C4D) and cortisone-treated guinea pigs. Atkinson JP; Shin H; Frank MM J Immunol; 1974 Oct; 113(4):1085-92. PubMed ID: 4414646 [No Abstract] [Full Text] [Related]
28. Lupus erythematosus-like syndrome with a familial deficiency of C2. Douglass MC; Lamberg SI; Lorincz AL; Good RA; Day NK Arch Dermatol; 1976 May; 112(5):671-4. PubMed ID: 1275522 [TBL] [Abstract][Full Text] [Related]
29. [Systemic lupus erythematosus in hereditary complement 4 deficiency]. Klein G; Tappeiner G; Hintner H; Scholz S; Wolff K Hautarzt; 1984 Jan; 35(1):27-32. PubMed ID: 6706571 [TBL] [Abstract][Full Text] [Related]
30. Anti-nuclear factors and serum complement in systemic lupus erythematosus. MORSE JH; MULLER-EBERHARD HJ; KUNKEL HG Bull N Y Acad Med; 1962 Oct; 38(10):641-51. PubMed ID: 14476340 [No Abstract] [Full Text] [Related]
31. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. NILSSON UR; MUELLER-EBERHARD HJ J Exp Med; 1965 Aug; 122(2):277-98. PubMed ID: 14316946 [TBL] [Abstract][Full Text] [Related]
32. Precise standardization of reagents for complement fixation. KENT JF; FIFE EH Am J Trop Med Hyg; 1963 Jan; 12():103-16. PubMed ID: 14031993 [No Abstract] [Full Text] [Related]
33. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. Alper CA; Rosen FS J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005 [TBL] [Abstract][Full Text] [Related]
35. Antibodies to polynucleotides: distribution in human serums. Koffler D; Carr RI; Agnello V; Fiezi T; Kunkel HG Science; 1969 Dec; 166(3913):1648-9. PubMed ID: 5360590 [TBL] [Abstract][Full Text] [Related]
36. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. Petz LD; Fink DJ; Letsky EA; Fudenberg HH; Müller-Eberhard J J Clin Invest; 1969 Nov; 47(11):2469-84. PubMed ID: 4975569 [TBL] [Abstract][Full Text] [Related]